Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

OBJECTIVE: This study sought to assess the efficacy and safety of immunotherapy combined with single-agent chemotherapy as a second- or later-line setting for metastatic non-small cell lung cancer (NSCLC) and to provide clinical evidence for this treatment regimen. The predictive value of extracellu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dongna, Li, Lin, Wang, Mingzhao, Hu, Xingsheng, Jiang, Jun, Li, Weihua, Yang, Lin, Fan, Meng, Shi, Yuankai, Lv, Fang, Liu, Yutao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547148/
https://www.ncbi.nlm.nih.gov/pubmed/37795095
http://dx.doi.org/10.3389/fimmu.2023.1086479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547148/
https://www.ncbi.nlm.nih.gov/pubmed/37795095
http://dx.doi.org/10.3389/fimmu.2023.1086479

Ejemplares similares